Shots: Prominent oncology drugs like pembrolizumab and nivolumab were initially approved with weight-based dosing and gradually transitioned to fixed dozing. With the transformation in the dosing model, the average dose amount administered to patients increased dramatically in the Oncology Care Model Today, at PharmaShots, we have Jennifer Fernandez from The Oncology Network, shedding light on…